India's Drugs Technical Advisory Board decides against waiving clinical trials for In-vitro Diagnostics despite their approval in other countries due to biological, genetic, and environmental differences. This decision reflects the importance of local validation in ensuring IVD performance within the Indian context. The IVD market is projected to grow significantly.
